ACUTE MYELOID LEUKEMIA, IN RELAPSE
Clinical trials for ACUTE MYELOID LEUKEMIA, IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA, IN RELAPSE trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA, IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may boost stem cell transplants for tough leukemia
Disease control Not yet recruitingThis study tests a new approach for adults with relapsed or refractory acute myeloid leukemia (AML) who have active disease. It uses a radioactive drug (131I-apamistamab) combined with low-dose radiation and chemotherapy before a stem cell transplant. The goal is to see if this h…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 04:33 UTC
-
New CAR T-Cell therapy targets tough leukemia in early trial
Disease control Not yet recruitingThis study tests a new treatment called CCTx-001 for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The therapy uses specially engineered immune cells to find and attack leukemia cells. The trial aims to find the best dose and ch…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE1, PHASE2 • Sponsor: Advesya SAS • Aim: Disease control
Last updated May 17, 2026 04:30 UTC
-
CAR-T Follow-Up study aims to track Long-Term effects in blood cancer patients
Knowledge-focused Not yet recruitingThis study follows up with people who have relapsed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and received ARD103 CAR-T cells in an earlier trial. Researchers will monitor side effects and overall survival over time to better understand the long-term safety a…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Sponsor: ARCE Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 04:15 UTC